U.S. Congress Passes Omnibus Funding with Significant Increases for Medical Research

We have some good news, the United States Congress has passed the Omnibus spending package.  The package will fund the U.S. Government through fiscal 2016.  We should take note that this bill includes a $2 billion increase for the National Institute of Health (NIH), a 5% increase for the National Cancer Institute (NCI) and the Food and Drug Administration (FDA).  The bill also includes funding for the Department of Defense Medical Research Program with an allocation of $80 million for the Prostate Cancer Research Program. My only disappointment is that the DOD PCRP (Prostate Cancer Research Program) didn't receive additional [...]

By | December 20th, 2015|advocacy, DOD PCRP, FDA, NCI, NIH, Politics of Cancer, Uncategorized, United States|0 Comments

Prostvac In Combination With Yervoy Yields A Survival Advantage

There is some really exciting news on the horizon around immunotherapy for advanced prostate cancer. Bavarian Nordic, the pharmaseutical company that has, along with the National Cancer Institute (NCI), been running clinical trials on Prostvac has unoffically let it been known that Prostvac when combined with another investigational immunologic therapy, Yervoy, has helped to significantly extend survival in men with advanced prostate cancer. This finding which will formally be announced this Thursday at the ASCO GU Meeting in Orlando Florida results from a small early-stage trial conducted by the U.S. National Cancer Institute. This very small study of 30 men [...]

The Well Reviewed Guide to Advanced Prostate Cancer (A Survivor Perspective) Has Been Updated and is Now Available for a free Download

Somehow I have been negligent and not let people know that I have written and posted a major update of my “Guide to Advanced Prostate Cancer.” As in the past, it is available as a free download from the Malecare web site. Helping me to update the book was prostate cancer survivor Craig Pynn and my own caretaker, Wendy Lebowitz. Anyone reading the first edition will be surprised when you see how many changes and updates this edition has included. It now has a very extensive conversation about living in the world as a cancer survivor as well as more [...]

NCI Director Out of Touch with His Agency and with the Major Characteristics of Breast & Prostate Cancer Funding

Out-takes from an Interview in August 2013 with Brian Lamb, a journalist and the founder, executive chairman, and now retired CEO of C-SPAN  which provides coverage of the U,S. Congress as well as other public affairs events and Francis Collins an American physican-genetist who currently is the Director of the National Institute of Health (NIH) in Bethesda, Maryland.  Fact checking performed by Darryl Mitteldorf, Executive Director of Malecare.   Brian Lamb: Let me ask you about prostate cancer and breast cancer, the numbers, you probably have them but on that, I think from reading that more men get prostate cancer than women get [...]

By | January 24th, 2014|advocacy, NCI, Prostate Ponderings, Research, Uncategorized|2 Comments
スーパーコピーブランド ロレックススーパーコピー オメガスーパーコピー ブルガリスーパーコピー ブライトリングスーパーコピー カルティエスーパーコピー シャネル時計コピー IWCスーパーコピー フランクミュラースーパーコピー パネライスーパーコピー タグホイヤースーパーコピー ウブロスーパーコピー ガガミラノスーパーコピー ルイヴィトンスーパーコピー シャネルスーパーコピー エルメススーパーコピー グッチスーパーコピー ボッテガヴェネタスーパーコピー プラダスーパーコピー セリーヌスーパーコピー ロレックススーパーコピー ウブロスーパーコピー